In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Treating hyperkalaemia: A step towards achieving optimal RAASi therapy?
Session

Event : HFA Discoveries

Topic : Chronic Heart Failure

  • Session type : Industry Essentials
  • Date :
  • Organised by CHANGE IME in partnership with Leicester Diabetes Centre Sponsored by an unrestricted educational grant from AstraZeneca

1 presentation in this session

Treating hyperkalaemia: A step towards achieving optimal RAASi therapy?

Event : HFA Discoveries 2020

  • Session : Treating hyperkalaemia: A step towards achieving optimal RAASi therapy?
  • Speaker : P Ponikowski (Wroclaw,PL), A Coats (Warwickshire,GB), I Pina (Detroit,US), M Kosiborod (Kansas,US), M Crespo-Leiro (La Coruna,ES)
  • Organised by CHANGE IME in partnership with Leicester Diabetes Centre Sponsored by an unrestricted educational grant from AstraZeneca

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are